Results for tag: "Fareston"

The Fareston market is a subset of the larger breast cancer drug market. It is composed of drugs that are used to treat advanced or metastatic breast cancer. These drugs are typically used in combination with other treatments, such as chemotherapy, radiation, and hormone therapy. Fareston is a selective estrogen receptor modulator (SERM) that works by blocking the action of estrogen in the body. It is used to treat postmenopausal women with advanced or metastatic breast cancer. Fareston is a relatively new drug, having been approved by the US Food and Drug Administration (FDA) in 2007. It is currently available in the United States, Canada, and Europe. The drug is typically prescribed in combination with other treatments, such as chemotherapy, radiation, and hormone therapy. Some of the companies in the Fareston market include Novartis, Pfizer, AstraZeneca, and Eli Lilly. Show Less Read more